Ally Bridge Group (NY) LLC

CIK 0001822947 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Ally Bridge Group (NY) LLC reported 25 positions worth $113.1M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: DFTX (16.6%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$113.1M
2026 Q2
Positions
25
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
70.5%
Est. Net Flow (Q)
2026 Q2
10 / 25 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1DFTXDEFINIUM THERAPEUTICS INCCALL$18.8M16.64%400,000
2ABVXABIVAX SACALL$16.7M14.73%125,000
3NERVMINERVA NEUROSCIENCES INCSH$12.1M10.68%2,175,802
4PMNPROMIS NEUROSCIENCES INCSH$8.2M7.22%620,319
5TRAXFIRST TRACKS BIOTHERAPEUTICSSH$5.7M5.06%284,287
6AXSMAXSOME THERAPEUTICS INCSH$4.0M3.57%16,493
7ASMBASSEMBLY BIOSCIENCES INCSH$3.8M3.40%140,000
8WHWKWHITEHAWK THERAPEUTICS INCSH$3.7M3.31%817,939
9EWTXEDGEWISE THERAPEUTICS INCSH$3.4M2.99%83,300
10CLYMCLIMB BIO INCSH$3.2M2.87%249,172

The free plan shows the top 10 positions. The remaining 15 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Ally Bridge Group (NY) LLC hold as of Q2 2026?

Ally Bridge Group (NY) LLC reported 25 positions worth $113.1M in its Q2 2026 13F filing. Largest positions: DFTX (16.6%), ABVX (14.7%), NERV (10.7%), PMN (7.2%) and TRAX (5.1%).

What did Ally Bridge Group (NY) LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Ally Bridge Group (NY) LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.